Trial NCT00005047

View at ClinicalTrials.gov 
Org. Study IDs: CDR0000067639
Secondary IDs: CAN-NCIC-BL10 CCCWFU-88198 LAC-USC-4B951 NCI-G00-1715 NYU-9852 SWOG-4B951 U10CA032102

Last trial update was posted on 2017-06-08

MeSH Interventions

Doxorubicin Liposomal doxorubicin Methotrexate Vinblastine

MeSH Conditions

Urinary Bladder Neoplasms

Other Conditions

Bladder Cancer

Stopping Reasons

Accrual was halted on the basis of the Data and Safety Monitoring Board review of a futility analysis.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID